ISOTRETINOIN MEDICATION PROGRAM ALERTING RISKS OF TERATOGENICITY Trademark

Serial Number: 78144310

ISOTRETINOIN MEDICATION PROGRAM ALERTING RISKS OF TERATOGENICITY is a trademark filed by Ranbaxy Laboratories Limited on July 16, 2002. The trademark is classified under Class 42 (Computer & Scientific), Class 16 (Paper Goods). The application is currently no longer active.

Trademark Classes

42

Class 42 - Computer & Scientific

Scientific and technological services; industrial analysis and research services

16

Class 16 - Paper Goods

Paper and cardboard; printed matter; bookbinding material; photographs; stationery

Owner Contact Info

Ranbaxy Laboratories Limited (297 trademarks)

19 Nehru Place
New Delhi , IN

Entity Type: 03

Trademark Details

Filing Date

July 16, 2002

Registration Date

Not Registered

Goods & Services

printed instructional and educational materials used for counseling doctors to provide patients with information on the importance of pregnancy prevention while undergoing treatment with a pharmaceutical preparation associated with fetal abnormalities

counseling to doctors to provide patients with information on the importance of pregnancy prevention while undergoing treatment with a pharmaceutical preparation associated with fetal abnormalities